United States — Food and Drug Administration & Nasdaq-100
12 shared events · Importance 3 · Last updated May 14, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration approved Eli Lilly and Company's weight loss pill, Foundayo, impacting the pharmaceutical market.
Nasdaq-100: The Nasdaq-100 exchange also experienced more advancing issues than decliners, contributing to the overall positive market performance.
Apr 01, 2026 · 14 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration's delayed clearance for Caris Life Sciences' TriNav Advance product is a key factor contributing to the company's financial issues and the subsequent investor investigations.
Nasdaq-100: Nasdaq-100 is the stock exchange where Caris Life Sciences Inc. is publicly traded, and its stock price decline was observed on this exchange.
Jun 02, 2026 · 31 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration approved PEDMARK, a key product of Fennec Pharmaceuticals, which provides background on the company's operational success.
Nasdaq-100: The stock options were granted in accordance with Nasdaq-100 Listing Rule 5635(c)(4), indicating compliance with exchange regulations.
May 18, 2026 · 7 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration is currently reviewing the New Drug Application for rusfertide for the treatment of polycythemia vera.
Nasdaq-100: Nasdaq-100 is the exchange where AnBogen Therapeutics common stock is traded, and its rules govern the granting of inducement awards.
Jun 16, 2026 · 6 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration granted Breakthrough Therapy designation to Cadisegliatin, highlighting its potential importance in treating type 1 diabetes. This designation adds credibility to vTv Therapeutics's pipeline.
Nasdaq-100: Nasdaq-100 is mentioned as the exchange where vTv Therapeutics is listed and its rules (Nasdaq-100 Listing Rule 5635(c)(4)) govern the inducement grants.
Jun 02, 2026 · 7 articles
Business
Nasdaq-100: Nasdaq-100 is the stock exchange where Rhythm Pharmaceuticals, Inc. securities are traded.
Apr 01, 2026 · 7 articles
NEWSDESK
Explore this relationship live
Track how United States — Food and Drug Administration and Nasdaq-100 interact across events, view sentiment trends, and discover connected entities.
Open Dashboard